New framework for Parkinson’s stages is based on disease biology
Parkinson’s News Today reports on The Michael J. Fox Foundation For Parkinson’s Research’s (MJFF) proposed framework for defining and staging PD-based on its underlying biology rather than by hallmark disease symptoms.
A common marker of neurological diseases may play role in healthy brains
The news story features Team Gradinaru’s discovery that a protein called phosphorylated -synuclein, which is associated with several neurodegenerative diseases such as Parkinson's disease and Lewy body dementia, is also involved in the normal processes of how neurons communicate with each other in a healthy brain.
Michael J. Fox and Sergey Brin Take Their Push for a Parkinson’s Cure to the Next Level
Bloomberg News provides a deep dive into our work and our partnership with The Michael J. Fox Foundation. Working together, we're proud to be at the forefront of Parkinson’s disease research. Register for free to access the article.
Structures of Parkinson’s disease-linked proteins offer a framework for understanding how they work together
This story discusses Team Alessi’s research at St. Jude Children’s Research Hospital that used cryo-electron microscopy to characterize the interaction of two proteins implicated in Parkinson’s disease.
A substantial number of Parkinson’s disease cases can be attributed to preventable risk factors, new research finds
This news story discusses a research study by Team Liddle in Nature’s Parkinson’s Disease journal that found that preventable risk factors play a significant role in a person’s potential of developing Parkinson’s disease.
Tiny pieces of discarded plastics like styrofoam may promote Parkinson’s
This story reports on a research study by Team Liddle that found that nanoplastics that can reach a person’s brain can increase the risk of Parkinson’s disease or its progression by prompting the protein alpha-synuclein to clump and turn toxic.
